Bell Rock Capital’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bell Rock Capital’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,656	Closed	-$217K	–	80
2020 Q1	$217K	Sell	1,656 -207	-11%	-$29.5K	0.34%	57
2019 Q4	$278K	Sell	1,863 -522	-22%	-$71.7K	0.24%	81
2019 Q3	$280K	Buy	2,385 +44	+2%	+$5.86K	0.25%	82
2019 Q2	$332K	Buy	2,341 +338	+17%	+$46.6K	0.29%	65
2019 Q1	$300K	Buy	2,003 +638	+47%	+$91.8K	0.17%	100
2018 Q4	$163K	Buy	1,365 +284	+26%	+$38.8K	0.11%	125
2018 Q3	$168K	Buy	1,081 +482	+80%	+$72.9K	0.08%	149
2018 Q2	$85K	Buy	+599	New	+$82.3K	0.04%	203

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Bell Rock Capital's FBT Position: Q2 2020 in Review

Bell Rock Capital sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2020, closing a stake of 1,656 shares — an estimated $217K sold.

Bell Rock Capital first reported a position in FBT in Q2 2018 and held it in 8 quarters. The position peaked at $332K in Q2 2019. 224 funds tracked by Wall St. Rank hold FBT as of Q2 2020.

Bell Rock Capital reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2020 after selling out during the quarter.
Bell Rock Capital sold 1,656 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2020, an estimated $217K.
Bell Rock Capital first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2018 and held it in 8 quarters.
Bell Rock Capital's First Trust NYSE Arca Biotechnology Index Fund position peaked at $332K in Q2 2019.
224 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2020.

Based on Bell Rock Capital's 13F filing for Q2 2020, filed 4 Aug 2020.